[Federal Register Volume 88, Number 149 (Friday, August 4, 2023)]
[Notices]
[Page 51844]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-16685]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Office of the Director, National Institutes of Health; Notice of 
Meeting

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of a meeting of the Novel and 
Exceptional Technology and Research Advisory Committee.
    The meeting will be held as a virtual meeting and will be open to 
the public as indicated below. Individuals who plan to view the virtual 
meeting and need special assistance or other reasonable accommodations 
to view the meeting should notify the Contact Person listed below in 
advance of the meeting. The meeting will be videocast and can be 
accessed from the NIH Videocasting and Podcasting website (https://videocast.nih.gov/).

    Name of Committee: Novel and Exceptional Technology and Research 
Advisory Committee.
    Date: August 29, 2023.
    Time: 2:00 p.m. to 4:30 p.m.
    Agenda: The Novel and Exceptional Technology and Research 
Advisory Committee meeting will include presentation, discussion, 
and possible finalization of the Draft Report of the Working Group 
on Data Science and Emerging Technology and will include discussion 
of next steps for the Committee.
    Place: National Institutes of Health, 6705 Rockledge Drive, 
Suite 630, Bethesda, MD 20892 (Virtual Meeting Link will be 
available at https://osp.od.nih.gov/policies/novel-and-exceptional-technology-and-research-advisory-committee-nextrac#tab4/).
    Contact Person: Jessica Tucker, Ph.D., Office of Science Policy, 
National Institutes of Health, 6705 Rockledge Drive, Suite 630, 
Bethesda, MD 20892, 301-496-9838, [email protected].

    Members of the public may request to make an oral public comment 
or may submit written public comments. To sign up to make an oral 
public comment, please submit your name, affiliation, and short 
description of the oral comment to the Contact Person listed on this 
notice at least two business days prior to the meeting date. Once 
all time slots are filled, only written comments will be accepted. 
Any interested person may file written comments by forwarding the 
statement to the Contact Person listed on this notice at least two 
business days prior to the meeting date. The statement should 
include the name, address, telephone number and, when applicable, 
the business or professional affiliation of the interested person. 
Other than name and contact information, please do not include any 
personally identifiable information or any information that you do 
not wish to make public. Proprietary, classified, confidential, or 
sensitive information should not be included in your comments. 
Please note that any comments NIH receives may be posted unredacted 
to the Office of Science Policy website.
    Information is also available on the NIH Office of Science 
Policy website: https://osp.od.nih.gov/policies/novel-and-exceptional-technology-and-research-advisory-committee-nextrac#tab4, 
where an agenda, link to the webcast meeting, and any additional 
information for the meeting will be posted when available. Materials 
for this meeting will be posted prior to the meeting. Please check 
this website for updates.

(Catalogue of Federal Domestic Assistance Program Nos. 93.14, 
Intramural Research Training Award; 93.22, Clinical Research Loan 
Repayment Program for Individuals from Disadvantaged Backgrounds; 
93.232, Loan Repayment Program for Research Generally; 93.39, 
Academic Research Enhancement Award; 93.936, NIH Acquired 
Immunodeficiency Syndrome Research Loan Repayment Program; 93.187, 
Undergraduate Scholarship Program for Individuals from Disadvantaged 
Backgrounds, National Institutes of Health, HHS)

    Dated: August 1, 2023.
Victoria E. Townsend,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2023-16685 Filed 8-3-23; 8:45 am]
BILLING CODE 4140-01-P